Growth Metrics

Clorox (CLX) Liabilities and Shareholders Equity (2016 - 2025)

Clorox has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $5.6 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $5.6 billion for Q4 2025, up 0.65% from a year ago — trailing twelve months through Dec 2025 was $22.2 billion (down 1.84% YoY), and the annual figure for FY2025 was $5.6 billion, down 3.3%.
  • Liabilities and Shareholders Equity for Q4 2025 was $5.6 billion at Clorox, up from $5.5 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for CLX hit a ceiling of $6.4 billion in Q1 2021 and a floor of $5.5 billion in Q3 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $5.9 billion (2023), compared with a mean of $5.9 billion.
  • Peak annual rise in Liabilities and Shareholders Equity hit 10.1% in 2021, while the deepest fall reached 9.7% in 2021.
  • Clorox's Liabilities and Shareholders Equity stood at $6.2 billion in 2021, then dropped by 2.34% to $6.0 billion in 2022, then dropped by 2.27% to $5.9 billion in 2023, then fell by 5.6% to $5.6 billion in 2024, then grew by 0.65% to $5.6 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $5.6 billion (Q4 2025), $5.5 billion (Q3 2025), and $5.6 billion (Q2 2025) per Business Quant data.